欢迎来到创赛优选商城 !
Cy3-UTP(10mM) 抑胃肽酶液 PERFEMIKER AuroraGel 标准型基质胶,不含LDEV
光引发剂LAP 人工胃液 1%柠檬酸钠缓冲液 Salkowskis比色液 人工脑脊液(aCSF,无菌)
简介:酒石酸卡巴拉汀,Rivastigmine酒石酸盐是胆碱酯酶抑制剂,IC50为5.5 uM,还能抑制丁酰胆碱酯酶和乙酰胆碱酯酶。
酒石酸卡巴拉汀物理化学性质:
沸点
316.2ºC at 760 mmHg
熔点
123-1250C
分子式
C18H28N2O8
分子量
400.423
闪点
145ºC
精确质量
400.18457
PSA
147.84
LogP
0.6371
外观性状
白色至灰白色粉末
蒸汽压
0.000416mmHg at 25°C
储存条件
-20°C Freezer
水溶解性
可溶于:甲醇
酒石酸卡巴拉汀详细介绍:
中文名称:
酒石酸卡巴拉汀
中文别名:
酒石酸卡巴拉汀;(S)-N-乙基-N-甲基氨基甲酸-3-[(1-二甲氨基)乙基]苯酯酒石酸盐;卡巴拉汀或利斯的明酒石酸盐;L-酒石酸卡巴拉汀;2,3',4-三溴二苯醚;N-乙基甲基氨基甲酰氯;Rivastigmine L-Tartrate L-酒石酸卡巴拉汀;酒石酸卡巴拉汀 USP标准品;酒石酸卡巴拉汀Rivastigmine tartrate;酒石酸卡巴拉汀标准品;酒石酸卡巴拉汀氢 EP标准品;酒石酸利凡斯的明;卡巴拉丁;卡巴拉汀酒石酸盐;重酒石酸卡巴拉汀;重酒石酸利凡斯的明;(S)-N-乙基-N-甲基氨基甲酸-3-[(S)-1-(二甲氨基)乙基]苯酯酒石酸盐;氘代重酒石酸利斯的明-d6;酒石酸卡巴拉汀 中文别名:卡巴拉汀或利斯的明酒石酸盐;酒石酸利伐斯的明;酒石酸利瓦斯汀;利斯的明酒石酸盐;卡巴拉汀重酒石酸盐
英文名称:
(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate
英文别名:
(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate;RIVASTIGMINE TARTRATE SALT;SDZ-ENA 713;Ethylmethyl-carbamic Acid 3-[(1S)-1-(Dimethylamino)ethyl]phenyl Ester, Bitartrate;(S)-N-Ethyl-3-[(1-dimethylamino)ethyl]-N-methylphenylcarbamate hydrogen tartrate;Rivastigmine-d6 tartarate;Rivastigmine Tartrate;Rivastigmine (tartrate);Rivastigmine Hydrogen Tartrate;Rivastigmine Tartrat;3-[(S)-1-(Dimethylamino)ethyl]phenyl N-Ethyl-N-methylcarbamate L-Tartrate;ENA 713;N-Ethyl-N-methylcarbamic Acid 3-[(S)-1-(Dimethylamino)ethyl]phenyl Ester L-Tartrate;Rivastigmine;RivastigMine L-Tartrate;ENA-713;Ethylmethyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester;N-Ethyl-N-methyl-carbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester tartrate;S-Rivastigmine tartrate;Rivastigimine tartrate;rivastigMine ditartrate;RivastigMine Bitartrate
CAS号:
129101-54-8
分子式:
C14H22N2O2.C4H6O6
分子量:
400.42
详细描述:
创赛优选提供129101-54-8,酒石酸卡巴拉汀,Rivastigmine Tartrate,Medlife,上海现货。
Medlife,致力于提供高品质、高性价比小分子化合物的产品。
Medlife小分子化合物大量库存,提供超过2万种的抑制剂、激动剂、拮抗剂等产品,是药物及疾病研究的重要原料供应商。
AChR抑制剂,Rivastigmine酒石酸盐是胆碱酯酶抑制剂,IC50为5.5 uM,还能抑制丁酰胆碱酯酶和乙酰胆碱酯酶。
查询关键词:“129101-54-8,酒石酸卡巴拉汀,Rivastigmine Tartrate,PC14130,Medlife,上海现货”。
酒石酸卡巴拉汀参考文献:
[1]. Kurz A, Farlow M, Lefèvre G. Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review. Int J Clin Pract. 2009 May;63(5):799-805.
[2]. Polinsky RJ. Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Clin Ther. 1998 Jul-Aug;20(4):634-47.
[3]. Stryjer R, Ophir D, Bar F et al. Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia. Clin Neuropharmacol. 2012 Jul-Aug;35(4):161-4.
[4]. Han HJ, Lee JJ, Park SA et al. Efficacy and safety of switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch in patients with probable Alzheimer's disease. J Clin Neurol. 2011 Sep;7(3):137-42.
创赛客服1
创赛客服2
创赛客服3
创赛客服4
400-608-7598